Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II study begins for BKM-120 in recurrent glioblastoma

May 18, 2011

New anticancer antofine and cryptopleurine derivatives disclosed

May 18, 2011

AlloStem Therapeutics designs novel MEK inhibitors

May 18, 2011

Crizotinib NDA filed in Japan for ALK-positive NSCLC and accepted for priority review in U.S.

May 17, 2011

Swissmedic approves Eisai's Halaven for breast cancer

May 17, 2011

Korean scientists claim new protein kinase inhibitors

May 17, 2011

Tranzyme Pharma discloses new serine protease inhibitors

May 17, 2011

Roche begins phase Ib/II study of TB-403 in brain cancer

May 16, 2011

Clavis Pharma licenses anticancer candidate CP-4033 to Translational Therapeutics

May 16, 2011

Sigma-Tau researchers disclose novel HD6 inhibitors

May 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...